System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Review Ppublish 49 citations

PubMed: 35869679 DOI: 10.1002/ehf2.14076

Impact analysis of heart failure across European countries: an ESC-HFA position paper.

ESC Heart Fail 9(5):2767-2778

Authors: Giuseppe M C Rosano, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Yuri Lopatin, Fin Gustafsson, Antoni Bayes-Genis, Tiny Jaarsma, Magdy Abdelhamid, Arantxa Gonzalez Miqueo, Massimo Piepoli, Carlo G Tocchetti, Arsen D Ristić, Ewa Jankowska, Brenda Moura, Loreena Hill, Gerasimos Filippatos, Marco Metra, Davor Milicic, Thomas Thum, Ovidiu Chioncel, Tuvia Ben Gal, Lars H Lund, Dimitrios Farmakis, Wilfried Mullens, Stamatis Adamopoulos, Michael Bohm, Anna Norhammar, Andreas Bollmann, Amitava Banerjee, Aldo P Maggioni, Adriaan Voors, Alain Cohen Solal, Andrew J S Coats

Affiliations

  • Centre for Clinical & Basic Research, IRCCS San Raffaele Pisana, via della Pisana, 235, 00163, Rome, Italy.
  • Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
  • Regional Cardiology Centre, Volgograd State Medical University, Volgograd, Russia.
  • Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, CIBERCV, Barcelona, Spain.
  • Department of Health, Medicine and Care, Linköping University, Linköping Sweden and Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Faculty of Medicine, Cairo University, Giza, Egypt.
  • Program of Cardiovascular Diseases, CIMA Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Heart Failure Unit, Cardiology Department, Guglielmo da Saliceto Polichirurgico Hospital Cantone del Cristo, Piacenza, Italy.
  • Department of Translational Medical Sciences, Interdepartmental Center of Clinical and Translational Research (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.
  • Department of Cardiology, University Clinical Centre of Serbia, Belgrade, Serbia.
  • Wroclaw Medical University, Wroclaw, Poland.
  • Faculty of Medicine, University of Porto, Porto, Portugal.
  • School of Nursing and Midwifery, Queen's University Belfast, Belfast, UK.
  • Heart Failure Unit, Athens University Hospital Attikon, Athens, Greece.
  • Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
  • University of Zagreb School of Medicine, Zagreb, Croatia.
  • Hannover Medical School, Institute of Molecular and Translational Therapeutic Strategies, Hanover, Germany.
  • Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania.
  • Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
  • University of Cyprus Medical School, Nicosia, Cyprus.
  • Faculty of Medicine and Life Sciences, BIOMED-Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Onassis Cardiac Surgery Center, Athens, Greece.
  • Saarland University Hospital, Homburg, Germany.
  • Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany.
  • University College London, London, UK.
  • ANMCO Research Center, Florence, Italy.
  • University Medical Center Groningen, Groningen, The Netherlands.
  • Hospital Lariboisiere, Paris, France.
  • University of Warwick, Coventry, UK.

Abstract

Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.

MeSH

Quality Of Life, Mortality, Heart Failure, Heart, Prevalence, Morbidity, Therapeutics

Cited by